Infant Bacterial Therapeutics AB (publ) IBT-B.ST
IBT-B.ST
Infant Bacterial Therapeutics AB (publ) XSPRAY.ST
Xspray Pharma AB (publ) CANTA.ST
Cantargia AB (publ) ONCO.ST
Oncopeptides AB (publ) SEZI.ST
Senzime AB (publ) SYNACT.ST
SynAct Pharma AB ITECH.ST
I-Tech AB CLBIO.ST
Corline Biomedical AB GUARD.ST
Guard Therapeutics International AB (publ) ADDV-B.ST
ADDvise Group AB (publ)
Infant Bacterial Therapeutics AB (publ) XSPRAY.ST
Xspray Pharma AB (publ) CANTA.ST
Cantargia AB (publ) ONCO.ST
Oncopeptides AB (publ) SEZI.ST
Senzime AB (publ) SYNACT.ST
SynAct Pharma AB ITECH.ST
I-Tech AB CLBIO.ST
Corline Biomedical AB GUARD.ST
Guard Therapeutics International AB (publ) ADDV-B.ST
ADDvise Group AB (publ)
Performance
| Periode | IBT-B.ST | XSPRAY.ST | CANTA.ST | ONCO.ST | SEZI.ST | SYNACT.ST | ITECH.ST | CLBIO.ST | GUARD.ST | ADDV-B.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 12.34 % | -29.01 % | 50.32 % | 171.20 % | 15.34 % | 22.37 % | -2.04 % | 102.96 % | 91.47 % | -17.01 % |
| YTD | 4.70 % | -40.23 % | 37.94 % | 227.85 % | 4.39 % | 136.36 % | 28.33 % | 100.84 % | 27.52 % | -71.28 % |
| 1Y | 63.76 % | -55.49 % | -20.51 % | 147.85 % | -0.83 % | 148.31 % | 57.79 % | 138.21 % | 14.99 % | -79.57 % |
| 3Y | 7.13 % | -54.66 % | -36.17 % | -41.34 % | -26.58 % | -54.99 % | 55.87 % | 125.35 % | -27.44 % | -80.91 % |
| 5Y | -56.82 % | -81.41 % | -95.81 % | -95.62 % | -71.17 % | -50.89 % | 16.67 % | 13.80 % | -62.40 % | -5.89 % |
| 10Y | 2.80 % | -16.24 % | -71.10 % | -83.09 % | 47.37 % | 342.79 % | 212.12 % | 70.20 % | -99.11 % | -63.46 % |
| From the beginning | 2.80 % | -16.24 % | -72.39 % | -83.09 % | -11.07 % | 342.79 % | 212.12 % | 89.30 % | -99.32 % | -65.54 % |